Navigation Links
MedImmune Announces Positive Clinical Results at PAS Annual Meeting,From Large Prospective Trial in Prevention of Serious RSV Disease

eas of pediatric infectious diseases, cancer and inflammatory diseases. With more than 2,500 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at www.medimmune.com.

Forward Looking Statements

This announcement may contain, in addition to historical information, certain forward-looking statements regarding motavizumab, an investigational MAb, which involve risks and uncertainties. Such statements reflect management's current views and are based on certain assumptions. Actual results could differ materially from those currently anticipated as a result of a number of factors, including risks and uncertainties discussed in MedImmune's filings with the U.S. Securities and Exchange Commission. The company is developing motavizumab for potential future marketing. There can be no assurance that such development efforts will succeed, that motavizumab will receive required regulatory approval or that, even if such regulatory approval is received, that motavizumab would ultimately achieve commercial success.

Notice to Investors and Stockholders of MedImmune

This release is neither an offer to purchase nor a solicitation of an offer to sell shares of MedImmune. MedImmune stockholders are urged to read the relevant tender offer documents from AstraZeneca PLC which have been filed on May 3, 2007 because they will contain important information that stockholders should consider before making any decision regarding tendering their shares. AstraZeneca has filed tender offer materials with the U.S. Securities and Exchange Commission, and MedImmune has also filed a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the offer. The tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other offer documents) and the Solicitation/Recommendation Statement contain important informat
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:5/27/2015)... 2015 PharmaPoint: Type 1 Diabetes - Global Drug ... 1 diabetes (T1D) is an autoimmune disease that permanently destroys ... body can no longer produce insulin. Over the last 90 ... no other treatment can be offered to a patient who ... with different times of action - long-acting as well as ...
(Date:5/27/2015)... , May 27, 2015  Precision Advisors ( ... findings from its 2015 Digital Trends Study of 145 ... are aware of the concepts of big data and ... them.  The Health Information Technology for ... healthcare providers to make use of electronic medical records ...
(Date:5/27/2015)... May 27, 2015  LumiThera Inc., a developmental ... (PBM) treatment for ocular disorders and disease, announced ... Washington State Life Sciences Discovery Fund (LSDF) ... of the LSDF matching grants worth $500,000 to ... subjects with dry age-related macular degeneration (AMD). ...
Breaking Medicine Technology:PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 2Precision Advisors Digital Trends Study: Less Than Half of Managed Care Organizations Have Access to Electronic Medical Records Data 3LumiThera Receives LSDF Commercialization Grant Award 2
(Date:5/27/2015)... Ticket Down is a reputable source of 2015 NHL ... in the middle of their series against the Anaheim Ducks with ... the Blackhawks can win tonight at home, this will tie up ... at the Honda Center in Anaheim. , During the regular ... Conference as they won the Pacific Division by 8 points ahead ...
(Date:5/27/2015)... Hills, CA (PRWEB) May 27, 2015 Khanna ... of the art web portal focussed on keratoconus eye ... This relentless progressive disease has its onset in the teenage ... down. The cornea or the front clear part of the ... the pressure in the eye. It results in poor vision ...
(Date:5/27/2015)... 2015 Hundreds of Risperdal lawsuits ... individuals who allegedly suffered gynecomastia (male breast growth) ... the antipsychotic drug continue to move forward in ... Philadelphia Court of Common Pleas. According to court ... trial program, as the third trial involving Risperdal’s ...
(Date:5/27/2015)... 27, 2015 In today's healthcare landscape, ... it can be challenging for doctors and hospitals to ... treatments. , Austin-based HealthTronics, Inc. is ... mobile medical therapies for clinically sophisticated applications. The company ... acquisition of Laser Ventures, Inc ., a mobile ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a ... organizations, announced today that SanMar Corporation successfully implemented ... attendance and point tracking processes for over 3,000 ... , Family-owned since 1971, Seattle-based SanMar Corporation ... label, and mill brands. SanMar supplies apparel and ...
Breaking Medicine News(10 mins):Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 2Health News:Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Look Forward to Start of Third Gynecomastia Bellwether Trial in Pennsylvania 3Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3
... -- Scientists who first established a link between obesity ... the intestine now are investigating whether the organisms can ... Washington University School of Medicine in St. Louis, led ... malnourished infants living in Malawi and Bangladesh have a ...
... producer says they may have been mixed in during ... The salmonella contamination behind the recall of 1 ... nuts involved in processing at a California plant, according ... Cohen, production manager for Setton International Foods Inc. of ...
... best rankings had similar death rates to those with the ... task just got harder for patients trying to figure out ... study casts doubt on a hospital safety rating conducted by ... ranked in the highest quartile on the safety survey had ...
... 31, 2009 Formerly depressed women show patterns of ... that are distinctly different from the patterns shown by ... Harvard University. The participants reported being completely well and ... has been observed in depressed individuals in other studies. ...
... Successful Collaboration with the U.S. Army- U.S. FDA (Food ... new vaccine against Japanese Encephalitis for adult travelers and ... a result of an excellent collaboration between Intercell and ... U.S.- Supply contract for IXIARO with the U.S. military, ...
... Two Prestigious AwardsWEST ALLIS, Wis., March 31 /PRNewswire/ ... Center has two new awards among ... top 100 hospitals according to Thomson Reuters, and it ... a role model for others.(Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ) , ...
Cached Medicine News:Health News:$5.5 million from Gates Foundation funds major study of childhood malnutrition 2Health News:$5.5 million from Gates Foundation funds major study of childhood malnutrition 3Health News:$5.5 million from Gates Foundation funds major study of childhood malnutrition 4Health News:Raw Nuts Could Be Salmonella Source in Pistachios: Report 2Health News:Raw Nuts Could Be Salmonella Source in Pistachios: Report 3Health News:Study Casts Doubt on Influential Hospital Safety Survey 2Health News:Study Casts Doubt on Influential Hospital Safety Survey 3Health News:A mother's criticism causes distinctive neural activity among formerly depressed 2Health News:A mother's criticism causes distinctive neural activity among formerly depressed 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 2Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 4Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 5Health News:Aurora West Allis Medical Center Ranked Among the Top 100 U.S. Hospitals 2
... The ALU-1B Halogen Light source ... light source for routine use in ... has a turret which accepts the ... need for separate adapters. The ALU-1B ...
... Ultrasonic Lithotriptor LUS-2 combines two functions ... procedural performance and cost-efficiency. Boasting a ... helps to minimize hand fatigue for ... calculi while simultaneously removing the fragments ...
... MODULARIS Litho from Siemens Medical Solutions is ... management of stone disease. Urodiagnostics, endourology, lithotripsy, ... may all be part of a urologists ... the complete solution that supports the various ...
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
Medicine Products: